Back

Fixed combinations of renin-angiotensin-aldosterone system inhibitors and calcium channel blockers in relation of patients adherence in hypertension

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Hypertension treatment old and new Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Gabor Antal Simonyi

St Imre University Teaching Hospital, Budapest (Hungary)

9 More presentations in this session

Presentation thumbnail
Rates of adherence to modern antihypertensive drugs in resistant hypertension
Doctor E. Kocianova (Olomouc, CZ)
Abstract Slides
Presentation thumbnail
Non-steroid anti-inflammatory drug consumption decrease antihypertensive treatment efficacy in postenopausal women
Professor N. Izmozherova (Yekaterinburg, RU)
Abstract
Presentation thumbnail
Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients
Doctor A. Farcas (Cluj Napoca, RO)
Abstract
Presentation thumbnail
Long-term treatment with LCZ696 (sacubitril/valsartan) improves cardiac and renal function in stroke-prone spontaneously hypertensive rats
Professor Y. Takeda (Uchinada, JP)
Abstract Slides
Presentation thumbnail
Effect of perindopril/indapamide/amlodipine fixed-dose combination on peripheral and central hemodynamics and vascular wall stiffness parameters in patients with uncontrolled hypertension
Doctor T. Netchessova (Minsk, BY)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Hypertension treatment old and new

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel
thumbnail
Congress Presentation
Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?
thumbnail
Congress Presentation
Hypertension and glucose

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources